Retinol (vitamin A) circulates at 1-4 µM concentration and is easily measured in serum.
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Introduction:
Retinoids are acquired from the diet either as a proretinoid carotenoid or as retinol and retinyl esters (1) . Retinol (vitamin A) is the main circulating retinoid but it is biologically inactive and is metabolized in the body to active RA. RA has been reported to exist as at least 5 isomers including all-trans retinoic acid (atRA), 9-cisRA, 13-cisRA, 9,13-dicisRA and 11-cisRA (2) . These RA isomers are involved in numerous processes associated with vision, healthy skin, glucose regulation (3), embryonic development (4), stem cell differentiation (5) , and spermatogenesis (6) although the exact role of each isomer is not fully understood. atRA has been shown to induce remission in patients with acute promyelocytic leukemia (APL) and 13- cisRA (isotretinoin) is used for the treatment of acne and in children with high risk neuroblastoma (7). 9-cisRA (alitretinoin) has been used to treat severe chronic hand eczema (8) and shown to have a role in regulating insulin stimulated glucose secretion (3, 6, 9) . In addition to the RA isomers, the oxidized metabolites of RA including 4-hydroxy-RA (4OH-RA), 4oxo-RA, and RA-5,6-epoxide all possess biological activity in in vitro models (10) . 4oxo-RA has also been shown to be teratogenic in animal models and inhibit cell proliferation in a number of cell lines (11) (12) (13) .
The biological activity of retinoids is mediated predominantly by their association with nuclear receptors, mainly the retinoic acid receptors (RARα, RARβ and RARγ). However, binding of retinoids to retinoid X receptors (RXRα, RXRβ and RXRγ) and peroxisome proliferator-activated receptors PPAR (β/δ) has also been shown (14) . Oxidative metabolism of the RA isomers can result in either deactivation or activation of the parent retinoid, and isomerization of RA can change the specificity and activity of RA towards nuclear receptors.
For example, 9-cisRA binds to RXR with a significantly higher affinity than atRA and the 4oxo-atRA and 4OH-atRA have been shown to bind to RAR with similar affinity as atRA (10, 12, 15) .
The major limitation in understanding the roles and importance of 4OH-RA, 4oxo-RA and by guest, on October 30, 2017 www.jlr.org Downloaded from specific RA isomers in vivo, has been the lack of knowledge on the concentrations of the specific isomers and metabolites in human tissues.
Analysis of RA isomers and their metabolites has been difficult due to their similar structures and low concentrations in human tissues. Lack of analytical separation power may have confounded individual isomer detection whereas lack of good MS/MS sensitivity has prevented selective quantification of individual retinoids. Previous methods have been developed using LC-MS/MS (9, (16) (17) (18) (19) (20) (21) , GC/MS (22) , and LC/DAD/APCI-MS/MS (23) . However, none of these methods have incorporated measurement of hydroxylated RA metabolites at endogenous levels in serum. Endogenous atRA (4.6-5.8 nM), 13-cisRA (4.7-6 nM), and 4oxo-13-cisRA (8.1 -9.8 nM) were measured in human serum using HPLC with UV detection (24, 25) .
However, 9,13-dicisRA and 9-cisRA were not measured nor was separation of the main 4 isomers of RA demonstrated. Separation and quantification of atRA, 9-cisRA, 9,13-dicisRA and 13-cisRA in mouse tissues was shown using LC-MS/MS analysis (9) , but no measurement of the metabolites of RA was conducted.
The goal of this study was to develop a method for the simultaneous measurement of biologically active endogenous retinoids in human serum. Due to the challenges in separating the isomers of RA as well as the metabolites, chromatographic separation was optimized for UHPLC. The method was validated with spiked charcoal treated blank human serum and used to determine retinoid concentrations in serum from healthy men. The developed assay is useful for characterization of retinoid disposition and endogenous retinoid homeostasis and for following therapeutic interventions with retinoids. The method can also be used in preclinical studies of compounds that target changing retinoid concentrations. atRA, 9-cisRA, 13-cisRA, and 9-cis-retinal were purchased from Sigma (St. Louis, MO.) 4oxo-atRA, 4OH-atRA, and 9,13-dicisRA were synthesized as described below. 4oxo-13-cisRA, 4OH-9-cisRA, 4oxo-13-cisRA-d 3 , 13-cisRA-d 5 , and 11-cisRA were purchased from Toronto Research Chemicals (North York, Ontario). All compounds were stored in amber vials in ethanol as 1 mM stocks at -80°C. Acetonitrile, methanol, water, and formic acid used in the UHPLC-MS/MS method were from Fischer Scientific (Pittsburg, PA) and all were Optima LC/MS grade. Blank human serum (DC Mass Spect Gold MSG 4000) was purchased from Golden West Biologics (Temecula, CA). This serum has a normal range of triglycerides (30- 200 mg/dl) and cholesterol (> 20 mg/dl) to mimic the extraction environment of clinical samples. This is important due to the matrix effects associated with lipids during extraction and analyte ionization.
4OH-RA and 4oxo-RA were synthesized according to previously published methods (26, 27) . In brief, the methyl ester of atRA was generated using trimethylsilyldiazomethane. Methyl 4oxo-retinoate was prepared using activated MnO 2 in anhydrous dichloromethane. The 4oxo-RA-methyl ester was hydrolyzed using 2M KOH in methanol and 4oxo-atRA was extracted using ethyl acetate and crystallized. 4OH-atRA was synthesized from 4oxo-RA using 2 equivalents of NaBH 4 in methanol. The product was extracted with 1:1 mixture of ethyl acetate and ether, evaporated to dryness, and crystallized. 9,13-dicisRA was synthesized as previously published (28) . In brief, 100 mg of 9-cisretinal was dissolved in 20 mL of methanol. Eight mL of Tollens Reagent (equal volumes of 10% AgNO 3 and 10% NaOH mixed and titrated with ammonium hydroxide until precipitate dissolved) was added to the solution and the mixture was stirred at 37°C for 6 hours. The reaction was quenched with 4N HCl on ice, filtered, and the products extracted with hexane and evaporated to dryness. The mixture of 9-cisRA and 9,13-dicisRA was purified using silica by guest, on October 30, 2017 www.jlr.org Downloaded from gel chromatography and ethyl acetate:hexane mobile phase. The fraction of pure 9,13-dicisRA was quantified by NMR by calculating the ratio between the area of the 9-cisRA doublet at 6.09 ppm (H in C10) to the corresponding doublet from 9,13-dicisRA at 6.2 ppm. The identity of the 9,13-dicisRA was also confirmed by the ratio of the 9,13-dicisRA doublet at 7.7 ppm (H at C12) to the corresponding doublet in 9-cisRA at 6.3 ppm. Based on NMR quantification the reaction yielded 20% of 9,13-dicisRA and 80% 9-cisRA.
Extraction of retinoic acid isomers and 4oxo-retinoic acid:
All sample processing, preparation and extraction was conducted on ice under red light.
9-cisRA, 13-cisRA, atRA, 4oxo-13-cisRA, 4oxo-atRA, 4OH-atRA and 4OH-9-cisRA were spiked into blank serum. Into 500 µl of serum, 10 µl of a 60:40 ACN:MeOH mixture with 1 µM 13-cisRA-d 5 and 2 µM 4oxo-13-cisRA-d 3 was added as internal standards. All compounds were extracted according to previously described method for extraction of RA isomers (29) . In brief 1 mL ACN and 60 µL 4 N HCl were added to each sample, the samples were vortexed and retinoids were extracted twice with 5 mL of Hexanes. The organic phase was separated by centrifugation at 1000 rpm for 3 minutes and evaporated to dryness under Nitrogen stream at 32°C. The dry residue was reconstituted in 50 µL of 60:40 ACN:H 2 O and transferred to an amber autosampler vial.
Serum retinoids could also be measured with no extraction using a simple protein precipitation with ACN. In this method, 50 µl of ACN is added to 50 µl of serum followed by centrifugation at 2000 rpm for 10 minutes at 4°C to pellet serum proteins. The supernatant is transferred to a 96-well plate and 20 µl is injected into the UHPLC/MS/MS for analysis.
UHPLC MS/MS analysis:
The retinoids were separated using an Agilent 1290 UHPLC (Santa Clara, CA) equipped with a Sigma (St. Louis, MO) Ascentis Express RP Amide column (2.7 µm 150mm x 2.1 mm).
Gradient elution with a flow rate of 0.5 mL/min using water (A) and acetonitrile (B) with 40% by guest, on October 30, 2017 www.jlr.org Downloaded from 8 methanol and 0.1% formic acid in A and B was used. The gradient was from initial 60% (A) for 2 minutes to 45% (A) over 8 minutes and then to 10% (A) over 7 minutes. The column was then washed with 95% (B) for 3 minutes and returned to initial conditions. The column heater was set to 40°C. Samples were kept in the autosampler at 4°C and with the light turned off. 10 µL of sample was injected for analysis. Analytes were detected using an AB Sciex 5500 qTrap Q-LIT mass spectrometer (Foster City, CA) operated in positive ion APCI mode. The compound independent MS parameters were curtain gas: 20, collision gas: low, nebulizer current: 5, Temperature: 350°C, Ion Source Gas 1:80. The final compound dependent parameters used for analysis are summarized in Table 1 . The specific MS/MS transitions for each analyte were optimized using the Analyst software (Applied Biosystems, Foster City, CA) using direct infusion with and without the addition of the LC solvents. Initially, MS/MS transitions were identified for each analyte using the automatic optimization features of the Analyst software. These transitions were then compared with those from a manual optimization, and the five most abundant fragments for each analyte found in both the automatic and manual process were optimized independently for their declustering potential (DP), entrance potential (EP), collision energy (CE), and collision cell exit potential (CXP). All five identified potential MS/MS transitions for each analyte were then included in a method that was used to analyze blank, spiked and normal human serum to determine interference, matrix effects and signal to noise ratios of each MS/MS transition. The MS/MS transitions that showed the least amount of matrix interference in the blank serum and the highest signal to noise ratio in spiked samples were chosen for the final analysis.
Assay validation:
The assay was validated according to the published guidelines for bioanalytical method validation (30, 31) . The on column lower limit of detection (LLOD) determined as signal to noise by guest, on October 30, 2017 www.jlr.org Downloaded from ratio >3, and the on column lower limit of quantification (LLOQ) determined as signal to noise ratio >9 were measured for each compound as standard solution. The linearity of response was determined using standard curves generated over 4 orders of magnitude (0.0001-1 µM).
For quantification, blank serum was spiked at 6 concentrations between 0.1 nM and 20 nM for RA isomers and 0.5 nM and 20 nM for the metabolites to construct standard curves for each analyte. The peak area ratios of analyte/internal standard were plotted as a function of concentration. 13-cisRA-d 5 was used as the internal standard for quantification of atRA, 9-cisRA, 13-cisRA, and 9,13-dicisRA, and 4oxo-13-cisRA-d 3 for metabolite quantification. Each retinoid, with the exception of 9,13-dicisRA, were quantified using standard curves of the same compound. 9,13-dicisRA concentrations were measured using the standard curve for 9-cisRA after confirming that the MS/MS responses were identical for the two compounds using the NMR quantified standard. Quality Control (QC) samples were extracted along with each standard curve and run at the beginning, middle, and end of each run. All QC samples had accuracy and precision within published guidelines for bioanalytical method validation (30, 31) .
To determine the intraday and interday coefficients of variation (CV) the samples were extracted on three separate days. The CV was measured at the LLOQ for serum of each compound and at 7.5 nM of RA isomers and 10 nM of 4oxo-RA metabolites spiked into blank serum. The LLOQ in serum was determined by spiking 20 mL of blank serum with RA isomers and RA metabolites at concentrations of 0.05 nM (RA isomers) or 6 nM (metabolites). Aliquots of the QC samples were frozen and analyzed on 3 separate days. Due to their poor extraction recovery, the LLOQ (5 nM spiked in blank serum) of 4OH-atRA and 4OH-9-cisRA was determined following precipitation of serum proteins with acetonitrile, centrifugation of precipitated proteins and direct analysis of the supernatant as described above for retinoid extraction.
In order to determine whether matrix effects altered the ionization and detection of retinoids in serum, 4 serum samples were extracted and reconstituted in duplicate with 50 µl of 
Subjects:
Serum samples were collected from 20 healthy men between the ages 18 and 65 who were enrolled in a study examining the relationship between retinoids and spermatogenesis.
The study was approved by the Institutional Review Board at the University of Washington, and all subjects gave written informed consent prior to any study procedures. These men all exhibited normal blood chemistry, liver function, hematology and hormones. Subjects were excluded from the study if they used anabolic steroids, illicit drugs, or ingested more than 4 alcoholic drinks a day, or were being treated with ketoconazole, finasteride, dutasteride, methadone, or lithium. The first set of blood was collected between 8 am and 12 noon, during a fed state within 2-6 hours of breakfast. The 2 nd blood draw occurred at least 7 days after the first one, and blood was collected between 8 am and 12 noon after an overnight fast of at least
Correlation between data sets was tested with linear regression. For all comparisons a p-value of 0.05 was considered significant.
Analysis of the human serum samples and confirmation of analyte identity:
All the serum samples were analyzed using the described method. In addition the identities of the quantified retinoids were confirmed by collecting MS/MS spectra of each analyte. For this analysis 4 serum samples were extracted with hexanes as described above and the hexane phases were combined. After drying with Nitrogen, the sample was for the maximum amount of ions to be collected in the linear ion trap for best sensitivity was used to collect the fragment ion spectra.
To confirm that each quantified peak for the detected RA isomers in serum represented only a single compound, two independent MS/MS transitions from the extracted serum samples were monitored and the response ratio across the peak was recorded. If a peak consists of two compounds, the ratio between the two transitions will usually change across the Despite extensive efforts, 11-cisRA could not be separated chromatographically from the 9,13-dicisRA. In order to determine whether the retinoid detected in human serum was 9,13-dicisRA or 11-cisRA, palladium(II)nitrate was used to convert 11-cisRA to atRA according to a published method (33) . Four light protected serum samples were pooled to obtain a total volume of 2.5 mL of serum. 13-cisRA-d 5 was spiked into the sample to a final concentration of 20 nM as an internal standard. A 1.1 mL aliquot was removed from the pooled sample, and 5 nM 11-cisRA was spiked into the sample. Two 500 µl aliquots were collected from both the 11- 
Results:
Optimization of chromatographic separation and MS/MS detection of retinoids:
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The ionization and fragmentation of the retinoids was evaluated using electrospray and To achieve separation of the five RA isomers (atRA, 9-cisRA, 9,13-dicisRA, 11-cisRA and 13-cisRA), 4OH-RA isomers and 4oxo-RA isomers, numerous C18 and C8 columns with UHPLC capability were evaluated as well as several chiral columns with mobile phases including methanol, water, acetonitrile, acetic acid, and formic acid. Significant differences in the separation capacity between the different columns was observed, and in most columns the 13-cisRA and 9,13-dicisRA were not separated whereas separation between 13-cisRA and atRA was obtained in virtually all columns tested. Baseline separation of atRA, 9-cisRA, 9,13-dicisRA and 13-cisRA was achieved only using the amide column described and separation of the oxidized RA metabolite isomers was satisfactory (Figure 2 ). The 11-cisRA isomer could not be separated from the 9,13-dicisRA regardless of the analytical conditions ( Figure 4 ). Optimal separation of the oxidized metabolite isomers was achieved using a C18 column but the separation achieved using the amide column was sufficient for quantification. 
Validation of the method for serum samples:
The on column LLOD and LLOQ for clean standards for each analyte are shown in Figure 3 . Standard curves of atRA, 9-cisRA, 13-cisRA, 4oxo-atRA and 4oxo-13-cisRA were generated in blank human serum and extracted along with the study samples. The generated standard curves were linear and the equations with r 2 values are shown in Table 2 . The validation data at the LLOQ for serum (0.05 nM for RA isomers and 6 nM for 4oxo- and at the mid to high concentration (7.5 nM for RA isomers and 10 nM for 4oxo-13-cisRA) are shown in (accuracy) for all analytes at the mid-high QC and within 20% of the true value at LLOQ. The LLOD in serum for 4OH-RA isomers was 2 nM when the samples were analyzed after protein precipitation with acetonitrile. The retention times of the analytes were reproducible between days and within days with variability in the retention times being <0.5% for RA isomers and <0.8% for the metabolites. Lack of significant ion suppression or other matrix effects on retinoid detection was determined by comparing the peak areas for 13-cisRA-d 5 standard without matrix and 13-cisRA-d 5 in the sample spiked after extraction (100% recovery) at three different concentrations. The matrix consisting samples were not different in terms of peak area or retention time from the samples without matrix.
The effect of light exposure during sample collection to retinoid measurements was tested by comparing measurements from light protected samples to measurement in samples that were not collected in light protected conditions. All of the samples showed significant decreases (≈70%) in the concentrations of RA isomers demonstrating that protecting the samples from UV light already during sample collection is critical. No decrease in the concentrations of 4oxo-13cisRA were detected in response to light exposure (Data not shown).
Detection and identification of endogenous retinoids in human serum
The detection and separation of the endogenous RA isomers in serum is shown in Figure 2C and 2D with the identified retinoids indicated. As shown in Figure 4C with 11-cisRA spiked serum, 11-cisRA could not be separated from 9,13-dicisRA. However, treatment of serum with palladium(ii)nitrate converted the spiked 11-cisRA quantitatively to atRA ( Figure   4D ). In the non spiked sample no decrease in the 9,13-dicisRA peak area or increase in atRA peak area was detected confirming that 11-cisRA is not present in human serum.
The identitiy of each detected retinoid was confirmed by obtaining a MS/MS spectrum of the compound in serum (Figure 1 ). There were no detectable differences between the MS/MS spectra of 13-cisRA, 9,13-dicisRA, atRA and 9-cisRA nor between the 4oxo-13-cisRA and 4oxo-atRA. Analysis of the human serum samples allowed collection of a MS/MS spectrum for each RA isomer confirming the identity of the detected analytes. A representative MS/MS spectrum from human serum is shown in Figure 1B . Additionally, the fragmentation for endogenous compound 4oxo-13-cisRA ( Figure 1D ) was similar to the standard. Peak purity was confirmed by monitoring two separate SRM transitions for the RA isomers. The difference in the ratio between the two transitions (m/z 301>205 and m/z 301>123) remained constant across each peak in the standard and analyte in serum.
The hydroxylated metabolites, 4OH-9-cisRA and 4OH-atRA, were not detected in the samples extracted and analyzed using the method optimized for RA isomers ( Figure 2 ). To determine whether this was due to poor extraction recovery of 4OH-RA isomers, serum was analyzed also after precipitation of proteins with ACN followed by centrifugation. The ten serum samples analyzed had no quantifiable levels of 4OH-9-cisRA and 4OH-atRA ( Figure 5) showing that the concentrations of these metabolites, if they are present in human serum, are <2nM. It is possible that the two peaks detected in the serum ( Figure 5C ) are 4OH-RA isomers but this could not be confirmed, as experiments to obtain MS/MS spectra on these peaks were unsuccessful.
Quantification of retinoic acid isomers and metabolites in human serum:
Serum samples collected after an overnight fast and 2-6 hours after normal breakfast from 20 healthy men were analyzed to determine the normal concentrations of endogenous RA isomers and metabolites in human serum. All four RA isomers and 4oxo-13-cisRA were detected in all samples. 4oxo-atRA could also be detected in 18 of the total 40 samples, but the concentrations were below LLOQ. The concentration of 4oxo-13-cisRA could not be quantified in one subject at the fed state and in another subject in the fasted state, 9-cisRA could not be quantified in one sample from fed state, and 9,13-dicisRA could not be quantified in samples from two subjects in the fasted state since concentrations were below the LLOQ.
The mean concentrations of the four RA isomers and 4oxo-13-cisRA are shown in Table 3 and a box and whiskers plot representing the measured concentrations for each retinoid in the 20 volunteers is shown in Figure 6 . The most abundant RA isomer in human serum was 13-cisRA although atRA concentrations were only about 30-40% lower. The concentrations of atRA and 13-cisRA were about 10-fold higher than 9,13-dicisRA concentrations and 30-50 fold higher than 9-cisRA concentrations. Two of the RA metabolites, 4oxo-13-cisRA and 4oxo-atRA were also detected in human serum and the concentrations of 4oxo-13-cisRA exceeded those of 13-cisRA by 3-fold making this compound the most prevalent retinoid measured. No statistically significant differences (p>0.05) were found between the fed and fasted states for any of the detected analytes (Table 3) .
Linear regression analysis was used to determine whether correlations exist between the serum concentrations of the detected analytes. There was a significant correlation between the fed and fasted concentrations of 13-cisRA (p<0.001), 9,13-dicisRA (p<0.001) and 4oxo-13-cisRA (p<0.001), whereas the concentrations of atRA and 9-cisRA did not correlate between the fed and fasted states (p>0.05). In the fed state, there was a significant correlation between 9-cisRA and 13-cisRA (p<0.001), 9-cisRA and 9,13-dicisRA (p<0.001), 13-cisRA and 9,13-dicisRA (p<0.05), and 13-cisRA and 4oxo-13-cisRA (p<0.05). Interestingly no correlation (p>0.05) between atRA concentrations and any of the other retinoids was found in the fed state and in the fasted state atRA concentrations correlated only with 9-cisRA (p<0.01). In addition, in the fasted state, similar to the fed state, there was a significant correlation between 9-cisRA and 13-cisRA (p<0.001), 9-cisRA and 9,13-dicisRA (p<0.05) and 13-cisRA and 9,13-dicisRA (p<0.05).
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Discussion:
The decribed UHPLC MS/MS method is to date the most sensitive method to selectively monitor bioactive retinoids. The selectivity for RA isomers and metabolies is achieved using a combination of UHPLC, specfic solvents, and an amide column that provides the specific separation capacity needed for each isomer. Surprisingly, positive ion APCI ionization produced the best signal-to-noise ratio for the RA isomers despite the readily ionizable carboxylic acid group in the molecule. However, the RA metabolites exhibit better sensitivity using electrospray ionization and negative ion detection. For the quantification of the retinoids in serum, positive ion APCI was chosen because matrix interference was observed using electrospray ionization with negative ion and limited amount of biological samples may require a single analysis for all relevant bioactive retinoids. The best sensitivity for retinoid detection was obtained using a liquid-liquid extraction with hexanes and the method was validated for serum using this extraction method. However, the recovery of the hydroxylated metabolites is poor using the extraction method and a direct protein precipitation with acetonitrile is recommended for analysis of hydroxylated metabolites of RA. Similar extraction method as shown here for serum samples has been previously used for detection of atRA, 13-cisRA and 9,13-dicisRA in mouse tissues and hence the sample preparation is expected to be applicable for tissue analysis (9) . However, for any given tissue, especially the eye, a confirmatory analysis should be conducted to determine the potential presence of 11-cisRA and 9,13-dicisRA in the samples. In addition, special attention should be payed to the potential interfering compounds in the matrices analyzed. As demonstrated here, significant interference is present in many of the SRM transitions examined and it is expected that abundance and identity of interfering matrix compounds will vary between tissues. Since no blank tissues are generally available for retinoid analysis, simple transfer of a method validated for one tissue to another should be excercised with caution. as internal standards is that it allows monitoring of isomerization during sample preparation and analysis. When serum samples were exposed to light in this study, isomerization of the internal standard could be detected (data not shown). Deuterated standards can also be added into the samples during sample collection to control for stability during storage and freeze-thaw.
Despite the fact that only one isomer internal standard was used in this study, one may choose to add individual isomer standards to samples to confirm retention times of individual analytes.
The retinoid concentrations reported here are likely to represent average concentrations in healthy adult humans. Previous studies monitoring endogenous retinoid concentrations in the serum of men and women have not noted any differences between the two (24, 25) . The observed concentrations of atRA are lower and concentrations of 4oxo-13-cisRA are higher than what has been previously reported. The endogenous concentrations measured in this study are approximately 40% lower for atRA and about 80% higher for 4oxo-13-cisRA than previously reported (24, 25) . This may be due to improved assay selectivity in comparison to previous studies which used LC-UV, which may not have separated all RA and its metabolite isomers, or matrix interference. As shown in this study, a significant interference was detected eluting close to atRA but it was mainly detected at the mass transitions relevant for atRA-d 5 .
However, this interference would likely confound quantification in LC-UV assays. 
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The fact that 9-cisRA can be detected in human serum is of interest since 9-cisRA activates both RAR and RXR receptors and may have specific biological functions. In previous studies, endongeous 9-cisRA has not been detectable in human or mouse serum (8, 9, 29) , and dosing with alitretinoin (9-cisRA) was required to detect 9-cisRA in human serum (8) .
However, 9-cisRA was quantifiable in all but one of the samples in this study most likely due to the increased sensitivity of the UHPLC/MS/MS method. The identity of the detected 9-cisRA was confirmed by obtaining a MS/MS spectrum of the detected 9-cisRA. This detection of 9-cisRA is unlikely to be an artifact of the assay and/or result of isomerization since no isomerization of the internal standards was detected and the ratio between isomers did not change when samples were reanalyzed. In addition, 9-cisRA was detected in the samples after ACN precipitation as well as after extraction providing additional support for 9-cisRA being present in human serum. The 9-cisRA has also been detected in mouse pancreas and shown to regulate glucose homeostasis (3).
It is interesting that the ratio of RA isomers determined in human serum is different than what has been previously reported in mouse serum (9) . In mouse serum atRA was the most abundant retinoid with 9,13-dicisRA being present at similar concentrations. The concentrations of 13-cisRA were much lower than the two other detected retinoids. In contrast, in human serum 9,13-dicisRA was a minor circulating species and 13-cisRA was the most abundant retinoid. This demonstrates a significant species difference between the isomers. It is unlikely that the observed difference is due to isomerization in the two studies since the extraction methods were similar and both studies used LC-MS/MS. In addition, analysis of the human serum samples using the ACN precipitation protocol decribed here resulted in an identical ratio of RA isomers as seen with the extraction method. The preciptation method eliminates the potential for isomerization that may result from the extraction process that requires multiple pieces of glassware and the addition of acid. It is likely that the species difference is due to differences in the age and/or diet of the mice versus humans. The The results presented show no significant differences in retinoid serum levels after at least 8 hours of fasting despite the fact that a previous study discovered decreasing concentrations of atRA and 13-cisRA during fasting (25) . However, the previous study was conducted after a 5 day fast suggesting that the length of the fasting period will have an effect on the retinoid concentrations. One of the subjects in this study showed extremely high levels of 13-cisRA and 4oxo-13-cisRA compared to the mean. It was confirmed that this individual was not taking any exogenous retinoids during the study. While he was administered a prostaglandin F2α eyedrops, it is unlikely that these eyedrops affect 13-cisRA concentration in serum. The possibility of 13-cisRA and 4oxo-13-cisRA contamination in the samples is low, as his serum concentration was measured multiple times on different days. In studies involving isotretinoin treatment (80 mg m -2 b.d), the average concentration of 4oxo-13-cisRA was calculated to be approximately 4.7 µM (7), which is over 100-fold higher than the concentrations observed in this study. In a previous study, the effect of diet on atRA levels in serum was tested and atRA levels were shown to increase 100% after the consumption of carrot juice (34). However, no large increases in 13-cisRA concentrations were reported. The lack of correlation between atRA concentrations and the concentrations of other RA isomers suggests that measurement of at least atRA and 13-cisRA separately is necessary to characterize an individual's RA status. Since the different isomers have different pharmacological activity, separation of atRA and 13-cisRA from the other isomers is important in biological assays. 
